Concepedia

Xubin Bao

XB

Statistics

Publications

15

Citations

463

H-Index

12

Active since

2018

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Shanghai Jiao Tong University

Nanjing University of Chinese Medicine

Xubin Bao is an author at Shanghai Institute of Materia Medica specializing in medicine, pharmacology, and oncology.

Top concepts

Publications per year

2018–2024

15

Publications

15

Pharmacologic characterization of fluzoparib, a novel poly(<scp>ADP</scp>‐ribose) polymerase inhibitor undergoing clinical trials

Lei Wang, Changyong Yang, Chengying Xie et al. · Cancer Science · 2019 · 87 citations · Full text

Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models

Fei Long, Ye He, Haoyu Fu et al. · Cancer Science · 2019 · 79 citations · Full text

Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist

Chengying Xie, Huajun Zhao, Xubin Bao et al. · Journal of Cellular and Molecular Medicine · 2018 · 56 citations · Full text

Thioparib inhibits homologous recombination repair, activates the <scp>type I IFN</scp> response, and overcomes olaparib resistance

Li‐Min Wang, Pingyuan Wang, X. T. Chen et al. · EMBO Molecular Medicine · 2023 · 40 citations · Full text

Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer

Ning Zhang, Yunan Tian, Lina Zhou et al. · Cell Death and Disease · 2021 · 31 citations · Full text

1–5 of 15